Lupin Pharmaceuticals Inc. Glucagon Emergency Kit for Low Blood Sugar recall: CGMP deviation: OOS result observed for the Gliding Force functionality test
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
The hazard: Labelling or manufacturing-practice failure
This recall is about what the packaging says rather than what is in it — which still matters, because the label is how a dose gets chosen.
What the notice says: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Why it matters: The label, the strength printed on it, the barcode or the manufacturing records do not meet federal requirements. The practical danger is someone taking the wrong drug or the wrong dose while believing they have the right one.
Symptoms and when to call a doctor
If you may have taken a product that turned out to be a different drug or strength from the one on the label, call your prescriber, and call Poison Control on 1-800-222-1222 if you feel unwell. Describe what the pack said and what you actually took.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0723-2026
- Published
- July 8, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Lupin Pharmaceuticals Inc.
- Product type
- Prescription & OTC drugs
- Units affected
- 64,894 units
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Products covered by this recall
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
Check your product
The notice names 10 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- WB00010
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- Jan 2027
- Feb 2027
- Jun 2027
- Jul 2027
- Nov 2027. — 64
- 894 units
NDC number
On the carton and again on the bottle or blister label.
- 70748-311-01
Package size
Match the net weight or the piece count on the front of the pack.
- 1 mg
- 1 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Labelling
Lupin Pharmaceuticals Inc. — This recall is about what the packaging says rather than what is in it — which still matters, because the label is how a dose gets chosen.
- Compare the lot number and strength on your pack with the codes above and with what your prescription actually says.
- Report a mismatch to FDA MedWatch, especially if it reached you rather than being caught at the counter.
- If what you were dispensed does not match your prescription, call the pharmacy before taking another dose.
- Keep taking the medicine as prescribed unless the notice or your prescriber says otherwise.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: Lupin Pharmaceuticals Inc. — 5801 Pelican Bay Blvd Ste 500, Naples, FL, 34108-2734
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Lupin Pharmaceuticals Inc. prescription & otc drugs recalled?
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing. CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code WB00010; best-by date Jan 2027 or Feb 2027. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Compare the lot number and strength on your pack with the codes above and with what your prescription actually says.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · last month
Lupin Pharmaceuticals Inc. Clobetasol Propionate Cream USP, 0.05%, 60 g tube recall: Failed content uniformity specifications
Failed content uniformity specifications.
-
Class II · 4 months ago
Lupin Pharmaceuticals Inc. prednisoLONE Acetate Ophthalmic Suspension, USP, 1% recall: Presence of Foreign Substance
Presence of Foreign Substance
-
Class II · 5 months ago
Lupin Pharmaceuticals Inc. Liraglutide Injection, 18 mg/3 mL recall: Presence of particulate matter: a white thread-like structure in the cartridge
Presence of particulate matter: a white thread-like structure in the cartridge
-
Class II · 10 months ago
Lupin Pharmaceuticals Inc. Ganirelix Acetate Injection, 250 mcg/0.5mL recall: Failed impurities/degradation specifications: out of specification results
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
-
Class II · 10 months ago
Lupin Pharmaceuticals Inc. Sertraline Hydrochloride Tablets USP, 100 mg recall: Defective container - seal not adhering to bottles
Defective container - seal not adhering to bottles
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility